TYK Medicines (02410) submitted its Monthly Return for the period ended January 31, 2026, reporting no changes in the registered share capital. The total authorized/registered share capital remained at RMB380,065,818, comprising 375,457,818 H shares and 4,608,000 unlisted shares.

The company confirmed that 375,457,818 H shares and 4,608,000 unlisted shares were issued as of January 31, with no treasury shares. No changes were recorded in share options, warrants, or any convertible securities during the period. The company further confirmed compliance with the 25% public float requirement for its H shares.